Back to Raymond James Financial Inc. Raymond James Financial Inc.

ETON

8 quarters

Position history for Raymond James Financial Inc.Raymond James Financial Inc.'s holdings in Eton Pharmaceuticals, Inc.

Yes. Raymond James Financial holds 84,414 shares of ETON (Eton Pharmaceuticals), worth $4.3M, as of its Q3 2026 13F filing. It increased the position from 12,444 shares in Q2 2026. Raymond James Financial has held ETON in every 13F on record since Q4 2024, 8 quarterly filings.

Current Value

$4.3M

Current Shares

84,414

Total Value Change

+$4.2M

Total Shares Change

+73,371

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
84,414
+578.4%
$4.3M0.0%$51.49
43
2026-Q2
Increased
12,444
+1.6%
$450,4730.0%$36.20
24
2026-Q1
Unchanged
12,250
0.0%
$302,3300.0%$24.68
0
2025-Q4
Decreased
12,250
-85.9%
$207,1480.0%$16.91
0
2025-Q3
Decreased
87,082
-3.7%
$1.9M0.0%$21.73
0
2025-Q2
Increased
90,415
+15.6%
$1.3M0.0%$14.25
29
2025-Q1
Increased
78,213
+608.3%
$1M0.0%$12.98
40
2024-Q4
First report
11,043
-
$147,0930.0%$13.32
0

Other major holders of ETON: BlackRock, Inc., FMR LLC, State Street Corp., Geode Capital Management, LLC

Optional analytics helps us improve. How it’s used